东富龙收盘上涨2.65%，滚动市盈率71.48倍，总市值106.91亿元

Company Overview - Dongfulong Technology Group Co., Ltd. specializes in providing pharmaceutical process, core equipment, and system engineering solutions for global pharmaceutical companies [1] - The main product segments include bioprocessing, formulation, overall engineering solutions, and food equipment engineering [1] Financial Performance - For Q1 2025, the company reported revenue of 1.137 billion yuan, representing a year-on-year increase of 2.58% [1] - The net profit for the same period was 20.1326 million yuan, showing a significant year-on-year decline of 68.87% [1] - The sales gross margin stood at 24.45% [1] Market Position - As of July 24, the closing price of Dongfulong was 13.96 yuan, with a PE ratio of 71.48, marking a new low in 139 days [1] - The total market capitalization of the company is 10.691 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 54.55, with a median of 37.54, placing Dongfulong at the 95th position in the industry ranking [1][2] Institutional Holdings - As of Q1 2025, only one institution holds shares in Dongfulong, which is a fund with a total holding of 2.1845 million shares, valued at 2.9 million yuan [1]